Global Coronary Artery Bypass Grafts (CABG) Market 2017-2021

[junkie-button url=”” style=”grey” size=”medium” type=”round” target=”_blank”] HOME [/junkie-button]

Favorable Reimbursement Policies Driving Market Growth

The global coronary artery bypass grafts (CABG) market to grow at a CAGR of 5.83% during the period 2017-2021.

Global Coronary Artery Bypass Grafts (CABG) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

According to the report, one driver in the market is favorable reimbursement policies. Well-structured reimbursement policies for medical devices have been under consideration by insurance regulatory firms for some time now. These policies are quite favorable for patients in some countries. The change in reimbursement policies will drive the sales of CABG. In APAC, many countries such as Thailand, India, China, and Singapore have increased their GDP spending on public healthcare. With an increased spending on healthcare, the CABG market will grow significantly in the region.

Key vendors

  • Abbott
  • Medtronic
  • Terumo Medical

Other prominent vendors

  • Boston Scientific
  • Dextera Surgical
  • Edwards Lifesciences
  • Ethicon (a subsidiary of Johnson & Johnson)
  • Genesee BioMedical
  • Hancock Jaffe Laboratories
  • HeartWare
  • LivaNova
  • Neograft
  • Teleflex
  • Vitalitec

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By Application

Part 07: Market Segmentation By Product

Part 08: Market Segmentation By End-Users

Part 09: Regional Landscape

Part 10: Decision Framework

Part 11: Drivers And Challenges

Part 12: Market Trends

Part 13: Vendor Landscape

Part 14: Vendor Analysis

Part 15: Appendix